1. Home
  2. JQC vs CADL Comparison

JQC vs CADL Comparison

Compare JQC & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

JQC

Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

HOLD

Current Price

$4.77

Market Cap

709.5M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.27

Market Cap

723.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JQC
CADL
Founded
2003
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
709.5M
723.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JQC
CADL
Price
$4.77
$10.27
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
574.2K
2.0M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
11.13%
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$4.35
52 Week High
$5.58
$11.36

Technical Indicators

Market Signals
Indicator
JQC
CADL
Relative Strength Index (RSI) 41.34 61.25
Support Level $4.76 $4.87
Resistance Level $4.88 $11.36
Average True Range (ATR) 0.04 0.66
MACD -0.01 -0.06
Stochastic Oscillator 12.00 48.85

Price Performance

Historical Comparison
JQC
CADL

About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: